Stem Cell Therapy Asia

Stem Cell Therapy Asia is a leading regenerative medicine provider based in Bangkok, Thailand, operating under the StemCell21 medical group. The company specializes in the application of Mesenchymal Stem Cells (MSCs) and exosome therapies for a broad spectrum of medical conditions, including autoimmune diseases, degenerative orthopedic issues, and metabolic disorders. Their integrated approach combines a state-of-the-art GMP-certified laboratory for cell cultivation with specialized medical clinics for patient administration. SCTA serves an international clientele, offering personalized treatment protocols designed to enhance recovery and improve quality of life through advanced cellular biotechnology.